These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27529327)

  • 41. The treatment of neuromyelitis optica.
    Kowarik MC; Soltys J; Bennett JL
    J Neuroophthalmol; 2014 Mar; 34(1):70-82. PubMed ID: 24531318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
    Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
    Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neuromyelitis optica].
    Pache F; Wildemann B; Paul F; Jarius S
    Fortschr Neurol Psychiatr; 2017 Feb; 85(2):100-114. PubMed ID: 28235212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).
    Trebst C; Jarius S; Berthele A; Paul F; Schippling S; Wildemann B; Borisow N; Kleiter I; Aktas O; Kümpfel T;
    J Neurol; 2014 Jan; 261(1):1-16. PubMed ID: 24272588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic criteria in acute neuromyelitis].
    Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
    Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
    Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
    J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
    Matiello M; Schaefer-Klein J; Sun D; Weinshenker BG
    JAMA Neurol; 2013 Sep; 70(9):1118-25. PubMed ID: 23857303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
    Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
    Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.
    Argyriou AA; Makris N
    Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
    Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
    Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evolution of Devic's neuromyelitis optica spectrum disorders].
    Bernard-Valnet R; Marignier R
    Presse Med; 2015 Apr; 44(4 Pt 1):401-10. PubMed ID: 25535163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
    Papais-Alvarenga RM; Vasconcelos CC; Carra A; de Castillo IS; Florentin S; Diaz de Bedoya FH; Mandler R; de Siervi LC; Pimentel ML; Alvarenga MP; Alvarenga MP; Grzesiuk AK; Gama Pereira AB; Gomes Neto AP; Velasquez C; Soublette C; Fleitas CV; Diniz DS; Armas E; Batista E; Hernandez F; Pereira FF; Siqueira HH; Cabeça H; Sanchez J; Brooks JB; Gonçalves MV; Barroso MC; Ravelo ME; Castillo MC; Ferreira ML; Rocha MS; Parolin MK; Molina O; Marinho PB; Christo PP; Brant de Souza R; Pessanha Neto S; Camargo SM; Machado SC; Neri VC; Fragoso YD; Alvarenga H; Thuler LC
    PLoS One; 2015; 10(7):e0127757. PubMed ID: 26222205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuromyelitis optica: changing concepts.
    Jacob A; Matiello M; Wingerchuk DM; Lucchinetti CF; Pittock SJ; Weinshenker BG
    J Neuroimmunol; 2007 Jul; 187(1-2):126-38. PubMed ID: 17512987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seronegative Neuromyelitis Optica Spectrum Disorder: An Unusual Presentation of Acute Brainstem Syndrome.
    Alshurafa ZH; Alkhateeb MO
    Am J Case Rep; 2020 May; 21():e922590. PubMed ID: 32365056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.